Indoco Remedies Ltd (INDOCO)
₹322▲0.8%
🔔 Earnings Alert
Indoco Remedies Q1 net profit down 89.22% YoY, EPS at ₹0.2. 1 Buy, 1 Hold, 1 Strong Buy rating by analysts.
Analyst Rating
based on 5 analysts
60.00%
Buy
20.00%
Hold
20.00%
Sell
Based on 5 analysts offering long term price targets for Indoco Remedies Ltd. An average target of ₹356.4
Source: S&P Global Market Intelligence
Indoco Remedies Ltd Share analysis
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹316.7₹324.352 Week's Low
52 Week's High
₹286.6₹415
| Returns % | |
| 1 Month Return | -2.68 % |
| 3 Month Return | -2.9 % |
| 1 Year Return | -3.14 % |
| Market Stats | |
| Previous Close | ₹319.45 |
| Open | ₹316.70 |
| Volume | 1.10L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,944.76Cr |
Key Statistics
| P/E Ratio | 39.44 |
| PEG Ratio | -6.84 |
| Market Cap | ₹2,944.76 Cr |
| P/B Ratio | 2.92 |
| EPS | 15.44 |
Peer Comparison
Mutual Fund Holdings
Company Information
Share Price: ₹322.00 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹2,944.76Cr as of today
Revenue: ₹424.29Cr as on June 2024 (Q2 24)
Net Profit: ₹1.82Cr as on June 2024 (Q2 24)
Listing date: 14 Jan, 2005
Chairperson Name: Suresh G Kare
| Organisation | Indoco Remedies Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Indoco Remedies Ltd
Indoco Remedies Reports Decline in Sales and Profit - 24 Jul, 2024
Indoco Remedies reported a decline in net sales and quarterly net profit in June 2024. Additionally, the company's Q1 results showed a significant decrease in revenue and profit compared to the previous year.
Indoco Remedies Reports Decline in Standalone and Consolidated Net Sales - 23 Jul, 2024
Indoco Remedies reported a decline in both standalone and consolidated net sales for June 2024 compared to the same period last year. The company's quarterly net profit also decreased significantly YoY.
Ventura Securities Bullish on Indoco Remedies - 05 Jul, 2024
Vinit Bolinjkar of Ventura Securities is bullish on Indoco Remedies due to its cheap valuations, strong management, and product range. The company has taken measures to improve margins and has made significant investments. They are also carving out a new subsidiary for OTC products and have a strong brand in Sensodent. Bolinjkar expects the stock to reach a range of 700 to 1000 over the next three to four years.
Insights on Indoco Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 19.92% to 21.07% in Jun 2024 quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 58.72% to 58.75% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 90.3%
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 155.0%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 1.91% to 1.47% in Jun 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 472.03 Cr → 432.52 Cr (in ₹), with an average decrease of 8.4% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 17.91% to 17.04% in Jun 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, INDOCO stock has moved down by -27.3%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 22.7 Cr → 2.62 Cr (in ₹), with an average decrease of 88.5% per quarter
Company Financials
| Q'2 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹424.29Cr | ↓3.37% |
Net Income | ₹1.82Cr | ↓91.74% |
Net Profit Margin | 0.43% | ↓91.43% |
| 2023 | Y/Y Change | |
|---|---|---|
Revenue | ₹1,668.61Cr | ↑8.30% |
Net Income | ₹142.25Cr | ↓8.11% |
Net Profit Margin | 8.53% | ↓15.12% |
| 2023 | Y/Y Change | |
|---|---|---|
Total Assets | ₹1,685.89Cr | ↑11.11% |
Total Liabilities | ₹658.87Cr | ↑7.48% |
| 2023 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹175.59Cr | ↑1.18% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 58.75% | 0.05 | |
| Foreign Institutions | 1.47% | ||
| Mutual Funds | 17.04% | ||
| Retail Investors | 21.07% | 5.78 | |
| Others | 1.66% | 7.92 |
Key Indicators
Indoco Remedies Ltd Valuation
Indoco Remedies Ltd in the last 5 years
Lowest (-705.32x)
April 24, 2019
Today (39.44x)
July 23, 2024
Industry (56.07x)
July 23, 2024
Highest (242.71x)
September 6, 2018
Earnings and Dividends
Indoco Remedies Ltd Earnings Results
Indoco Remedies Ltd’s net profit fell -89.26% since last year same period to ₹2.62Cr in the Q1 2024-2025. On a quarterly growth basis, Indoco Remedies Ltd has generated -88.46% fall in its net profits since last 3-months.
Read More about Earnings ResultsIndoco Remedies Ltd Dividends May,2023
In the quarter ending March 2023, Indoco Remedies Ltd has declared dividend of ₹2.25 - translating a dividend yield of 0.70%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Indoco Remedies Ltd is currently in a Bearish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Indoco Remedies Ltd shares.
Indoco Remedies Ltd (INDOCO) share price today is ₹322
Indoco Remedies Ltd is listed on NSE
Indoco Remedies Ltd is listed on BSE
- Today’s highest price of Indoco Remedies Ltd is ₹324.3.
- Today’s lowest price of Indoco Remedies Ltd is ₹316.7.
PE Ratio of Indoco Remedies Ltd is 39.44
PE ratio = Indoco Remedies Ltd Market price per share / Indoco Remedies Ltd Earnings per share
Today’s traded volume of Indoco Remedies Ltd(INDOCO) is 1.10L.
Today’s market capitalisation of Indoco Remedies Ltd(INDOCO) is ₹2944.76Cr.
| Indoco Remedies Ltd(INDOCO | Price |
|---|---|
52 Week High | ₹415 |
52 Week Low | ₹286.6 |
Indoco Remedies Ltd(INDOCO) share price is ₹322. It is down -22.41% from its 52 Week High price of ₹415
Indoco Remedies Ltd(INDOCO) share price is ₹322. It is up 12.35% from its 52 Week Low price of ₹286.6
| Indoco Remedies Ltd(INDOCO | Returns |
|---|---|
1 Day Returns | 2.55% |
1 Month Returns | -2.68% |
3 Month Returns | -2.9% |
1 Year Returns | -3.14% |